Quantifying the burden of potentially inappropriate prescribed medicines among people hospitalised with heart failure in Australia: a comparison with ESC recommendations
Event:
Heart Failure 2025
Topic:
Pharmacotherapy
Session:
Vericiguat, SGLT2 inhibitors and implementation
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
